The global peptide therapeutics market is projected to grow at a significant CAGR of around 9.0% during the forecast period. Peptides have gained a wide range of applications in medicine and biotechnology. In the last five years (2015–2019), the US Food Drug Administration (FDA) has authorized a total of 208 new drugs, 15 of which were peptides or peptide-containing molecules, which account for 7% of the total number of drugs. The primary factor that drives the peptide therapeutics market growth includes the potent and specific, yet safe, mode of action of peptides.
Besides the increased prevalence of diseases such as cancer also drives the global peptide therapeutics industry growth during the forecast period. Increased rate of mortality due to cancer has led to an increase in emphasis on the advancements of the drugs and products to combat the situation, which fuels the growth for the global peptide therapeutics market over the forecast period.
A full report of Peptide Therapeutics Market is available at: https://www.omrglobal.com/industry-reports/peptide-therapeutics-market
Based on the route of the delivery segment of the market, oral held the key share in the market. Oral delivery is the preferred route of drug administration, as the majority of patients see it as the most convenient way to take their drugs. Drugs taken by the oral route have the highest level of patient compliance due to the ease and simplicity of taking medications. Despite a large number of protein therapeutics being discovered each year, oral delivery continues to be a barrier. As a whole, protein and peptide drugs have low bioavailability when administered orally due to problematic barriers including gastrointestinal proteases, the epithelial barrier, and efflux pumps.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/peptide-therapeutics-market
Further, the presence of the key players that provides suitable and proper drugs also drives the growth of the peptide therapeutics market during the forecast period. Players such as Amgen Inc., Eli Lilly and Co., Pfizer, Inc., Bristol-Myer Squibb Co., AstraZeneca Plc, F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Merck & Co. Inc., Novartis International AG, Novo Nordisk A/S, Takeda Pharmaceutical Co. Ltd., Teva Pharmaceuticals Industries Ltd., and others are some of the key players contributing to the growth of the market.
Global Peptide Therapeutics Market – Segmentation
By Route of Administration
- Oral
- Parenteral
By Application
- Cancer
- Gastrointestinal Disorders
- Central Nervous System Disorders
- Respiratory Disorders
- Others
Global Peptide Therapeutics Market – Segmentation by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- Amgen, Inc.
- AstraZeneca Plc
- Bachem Holding AG
- Bristol-Myers Squibb Co.
- CordenPharma InternationalGmbH
- Eli Lilly and Co.
- Hoffmann-La Roche Ltd.
- GlaxoSmithKline Plc
- Lonza Group AG
- Merck & Co. Inc.
- Novartis International AG
- Novo Nordisk A/S
- Pfizer, Inc.
- PolyPeptide Group
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404